
Chordia
190A.TChordia Therapeutics Inc. Price (190A.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
58,729,483
(4.0495)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales. Read More
- Previous Close Fetching Data...
- Range $142-930
- Market Cap 17.51B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Pharmaceuticals
- ceo: Mr. Hiroshi Miyake Ph.D.
- IPO Date: January, 01, 1970
- Country: JP
- Currency: JPY
- Headquaters: No Data
- Employees: No Data
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
